Viewing Study NCT02251860


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-01-07 @ 7:25 AM
Study NCT ID: NCT02251860
Status: COMPLETED
Last Update Posted: 2020-09-22
First Post: 2014-09-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module